Marina Cruz
- Epidemiology top 5%
- Hepatology top 1%
- Endocrinology, Diabetes and Metabolism top 10%
- Genetics
- Molecular Biology
- Co-authors
- Manuel Romero‐GómezLourdes GrandeMaría del Mar ViloriaPilar López SerranoMaría Luisa Gutiérrez GarcíaConrado Fernández‐RodríguezJavier SalmerónPaloma Muñoz‐de‐Rueda
- Topics
- Hepatitis C virus research (3 papers)Liver Disease Diagnosis and Treatment (3 papers)Hepatitis B Virus Studies (1 paper)
- Partner nations
- SpainBrazilSwitzerland
In The Last Decade
Marina Cruz
9 papers receiving 675 citations
Hit Papers
Peers
Comparison fields: 5 of 55
- Epidemiology 612
- Hepatology 572
- Endocrinology, Diabetes and Metabolism 100
- Genetics 63
- Molecular Biology 63
Countries citing papers authored by Marina Cruz
This map shows the geographic impact of Marina Cruz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marina Cruz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marina Cruz more than expected).
Fields of papers citing papers by Marina Cruz
This network shows the impact of papers produced by Marina Cruz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marina Cruz. The network helps show where Marina Cruz may publish in the future.
Co-authorship network of co-authors of Marina Cruz
This figure shows the co-authorship network connecting the top 25 collaborators of Marina Cruz. A scholar is included among the top collaborators of Marina Cruz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marina Cruz. Marina Cruz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 15 | |
| 3 | Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patientsbreakdown → | 556 |
| 4 | 3 | |
| 5 | 96 | |
| 6 | 2 | |
| 7 | 1 | |
| 8 | Thyroid disease in HCV carriers undergoing antiviral therapy with interferon plus ribavirin. | 19 |
| 9 | Natural killer cell function in cancer patients treated with natural leukocyte interferon-alpha. | 2 |
About Marina Cruz
Marina Cruz is a scholar working on Hepatology, Endocrine and Autonomic Systems and Endocrinology, Diabetes and Metabolism, having authored 9 papers that have together received 697 indexed citations. Recurring topics across this work include Hepatitis C virus research (3 papers), Liver Disease Diagnosis and Treatment (3 papers) and Hepatitis B Virus Studies (1 paper). The work is most often cited by research in Hepatology (572 citations), Epidemiology (612 citations) and Endocrinology, Diabetes and Metabolism (100 citations). Marina Cruz has collaborated with scholars based in Spain, Brazil and Switzerland. Frequent co-authors include Manuel Romero‐Gómez, Lourdes Grande, María del Mar Viloria, Pilar López Serrano, María Luisa Gutiérrez García, Conrado Fernández‐Rodríguez, Javier Salmerón, Paloma Muñoz‐de‐Rueda, Raquel Corpas and Luis Alberto Vázquez. Their work appears in journals such as Journal of Biological Chemistry, Gastroenterology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.